Successful control of heavily pretreated metastatic gastric cancer with the mTOR inhibitor everolimus (RAD001) in a patient with PIK3CA mutation and pS6 overexpression
Crossref DOI link: https://doi.org/10.1186/s12885-015-1139-7
Published Online: 2015-03-13
Published Print: 2015-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Park, Ji Hyun
Ryu, Min-Hee
Park, Young Soo
Park, Sook Ryun
Na, Young-Soon
Rhoo, Baek-Yeol
Kang, Yoon-Koo
License valid from 2015-03-13
Article History
Received: 17 May 2014
Accepted: 26 February 2015
First Online: 13 March 2015